Published in Ther Adv Hematol on June 01, 2011
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation (ARISTOTLE) | NCT00412984
An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome | NCT00809965
Secondary Prevention of Venous Thrombo Embolism (VTE). (RE-MEDY) | NCT00329238
Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients (MAGELLAN) | NCT00571649
Safety and Interactions of Direct Oral Anticoagulants with Antiarrhythmic Drugs. Drug Saf (2017) 0.75
The effect of excessive anticoagulation on mortality and morbidity in hospitalized patients with anticoagulant-related major hemorrhage. Arch Intern Med (2004) 2.11
International normalized ratio increase before warfarin-associated hemorrhage: brief and subtle. Arch Intern Med (2004) 1.55
Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels. Am J Med (2011) 1.48
Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism. Am J Cardiol (2005) 1.34
Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J Am Coll Cardiol (2011) 1.19
How many hospital pharmacy medication dispensing errors go undetected? Jt Comm J Qual Patient Saf (2006) 1.06
Pattern of infliximab utilization in rheumatoid arthritis patients at an academic medical center. Arthritis Rheum (2005) 1.06
Time trends in warfarin-associated hemorrhage. Am J Cardiol (2004) 1.02
Venous thromboembolic disease. J Natl Compr Canc Netw (2013) 1.01
Electronic alerts for hospitalized high-VTE risk patients not receiving prophylaxis: a cohort study. J Thromb Thrombolysis (2007) 0.99
Venous thromboembolic disease. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2006) 0.98
Anticoagulation-associated adverse drug events. Am J Med (2011) 0.96
Evaluation of dexmedetomidine versus propofol-based sedation therapy in mechanically ventilated cardiac surgery patients at a tertiary academic medical center. Crit Pathw Cardiol (2010) 0.95
Technology utilization to prevent medication errors. Curr Drug Saf (2010) 0.95
Anticoagulants: A Review of the Pharmacology, Dosing, and Complications. Curr Emerg Hosp Med Rep (2013) 0.95
Patient education program for venous thromboembolism prevention in hospitalized patients. Am J Med (2012) 0.94
Venous thromboembolic disease. J Natl Compr Canc Netw (2011) 0.93
Rivaroxaban: practical considerations for ensuring safety and efficacy. Pharmacotherapy (2013) 0.90
Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2008) 0.87
Dabigatran etexilate in clinical practice: confronting challenges to improve safety and effectiveness. Pharmacotherapy (2011) 0.85
Cardiology patient pages. Prevention of deep vein thrombosis and pulmonary embolism. Circulation (2004) 0.84
The nonpharmacist business manager: key qualifications and skills for success. Am J Health Syst Pharm (2011) 0.83
New oral anticoagulants for the treatment of venous thromboembolism: understanding differences and similarities. Drugs (2014) 0.82
New antithrombotics: the impact on global health care. Thromb Res (2011) 0.79
Medication errors in a pharmacy-based bar-code-repackaging center. Am J Health Syst Pharm (2006) 0.79
Venous thromboembolic events in hospitalised medical patients. Thromb Haemost (2009) 0.78
Venous thromboembolism in hospitalized patients with active cancer. Clin Appl Thromb Hemost (2013) 0.77
Prescription of fondaparinux in hospitalised patients. Thromb Haemost (2009) 0.77
Cost analysis of "bridging therapy" with low-molecular-weight heparin versus unfractionated heparin during temporary interruption of chronic anticoagulation. Am J Cardiol (2004) 0.77
Hospital budget implications of substituting dabigatran for warfarin in an anticoagulation service. Clin Appl Thromb Hemost (2011) 0.76
Effect of dabigatran on referrals to and switching from warfarin in two academic anticoagulation management services. Am J Cardiol (2013) 0.75
A Comparison of Drug Shortages in the Hospital Setting in the United States and Saudi Arabia: An Exploratory Analysis. Hosp Pharm (2016) 0.75
Comment: venous thromboembolism prophylaxis conversion in nonsurgical inpatients. Ann Pharmacother (2003) 0.75
Aligning pharmacy and health-system objectives to eliminate central-line-associated bacteremias. Am J Health Syst Pharm (2009) 0.75
Rivaroxaban to prevent pulmonary embolism after hip or knee replacement. Circulation (2012) 0.75
Dronedarone: a review of characteristics and clinical data. Crit Pathw Cardiol (2010) 0.75
Bridging Experience With Eptifibatide After Stent Implantation. Crit Pathw Cardiol (2016) 0.75
Interleukin-1 Blockade for the Treatment of Pericarditis. Eur Heart J Cardiovasc Pharmacother (2017) 0.75
Review of Nonformulary Medication Approvals in an Academic Medical Center. Jt Comm J Qual Patient Saf (2016) 0.75
Consultant's Playbook: A Survey of Pharmacy Consultant Experiences Among Hospitals In the University HealthSystem Consortium. P T (2013) 0.75
Impact of an immunoglobulin G-specific enzyme-linked immunosorbent assay on the management of heparin-induced thrombocytopenia. Pharmacotherapy (2013) 0.75
Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes. Thromb Haemost (2008) 0.75